Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

IviGene

2000 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
Description

Owner and operator of a biotechnology company intended to facilitate genetic research for the study of antigens. The company's services focus on incorporating an In Vivo Induced Antigen Technology which uses antibodies present in the blood of patients infected with or recently recovered from infection with a particular pathogen and help generate and screen antibodies that serve as probes to screen a genomic expression library of the pathogen in order to identify proteins that are specifically expressed during an actual human infection, enabling medical researchers to develop and innovate drugs using antibodies for treating and curing chronic diseases and for vaccine diagnostic and pharmaceutical development.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 12085 Research Drive
  • Alachua, FL 32615
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore IviGene’s full profile, request a free trial.

IviGene Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 20-Nov-2006 000 Completed Startup
2. Corporate 12-Mar-2001 000 000 000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

IviGene Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
UF Innovate Accelerator/Incubator 000 0000 000000 0
Xtl Biopharmaceuticals Corporation Minority 000 0000 000000 0

IviGene Executive Team (3)

Name Title Board
Seat
Contact
Info
Ann Perogulske-Fox Co-Founder
Jeffrey Hillman Ph.D Co-Founder & Chief Scientific Officer
Martin Handfield Ph.D Co-Founder